Böttger B, Thate-Waschke IM,Bauersachs R, Kohlmann T, Wilke T.  Preferences for anticoagulation therapy in aterial fibrilllation: the patients´view. Journal of Thrombosis and Thrombolysis. 2015 Nov; 40(4):406-415

Wilke T, Böttger B, Berg B, Groth A, Müller S, Botteman m, Yu S, Fuchs A, Maywald A.  Epidemiology of urinary tract infections in type 2 diabetes mellitus patients: An analysis based on a large sample of 456,586 German T2DM patients. Journal of Diabetes and its Complications. 2015, Volume 29 (8): 1015–1023

Groth A, Halder F, Fuchs A, Maywald U, Wilke T. Unterversorgung von Vorhofflimmer-Patienten mit oralen Antikoagulanzien in Deutschland. Der Kardiologe. 2015 Okt, 9(5):379-392

Wilke T, Mueller S, Groth A, Fuchs A, Seitz L, Kienhöfer J, Maywald U, Lundershausen R, Wehling M. Treatment-dependent and treatment-independent risk factors associated with the risk of diabetes-related events: a retrospective analysis based on 229,042 patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2015 Feb 3;14(1):14.

Müller S, Wilke T. Validation of the Adherence Barriers Questionnaire (ABQ) – An Instrument for Identifying Potential Risk Factors Associated With Medication-Related Non-Adherence. Value in Health. 2014;17(7):A512.

Wilke T, Groth A, Berg B, Sikirica M, Martin AA, Fuchs A, Maywald U. Non-Adherence And Non-Persistence Related To Glp-1 Therapy In Patients With Diabetes Mellitus Type 2 (T2dm): Analysis of A Large German Claims-Based Dataset And Comparison To Oral Anti-Diabetics. Value in Health. 2014;17(7):A359.

Böttger B, Thate-Waschke IM, Bauersachs R, Kohlmann T, Wilke T. Preferences Regarding The Attributes Of Oral Anticoagulants In Patients With Atrial Fibrillation Results Of A Discrete Choice Experiment. Value in Health. 2014;17(7):A495.

Petersen J, Wilke T, Mauss S, Heyne R, Herold C, Wiese M, Boeker K, Pichl T, Hueppe D. Real-life persistence and adherence in ETV treated chronic hepatitis b patients: results of a German prospective multicenter observational study.  J Hepatol Suppl. 2014;60(1):S423.

Böttger B, Wehling M, Bauersachs RM, Amann S, Schuchert A, Reinhold C, Kümpers P, Wilke T. Prevalence of renal insufficiency in hospitalised patients with venous thromboembolic events: A retrospective analysis based on 6,725 VTE patients. Thromb Res. 2014;134(5):1014–1019.

Wilke T, Groth A, Pfannkuche M, Harks O, Fuchs A, Maywald U, Krabbe B. Real life anticoagulation treatment of patients with atrial fibrillation in Germany: extent and causes of anticoagulant under-use. J Thromb Thrombolysis. 2014;Epub ahead of print